Nonsquamous non-small cell lung cancer, Nonsquamous non-small cell lung cancer research hub

A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell lung cancer who have progressed on immunotherapy

This study is testing a new medicine, inupadenant, combined with standard chemotherapy for adults in the UK with a type of lung cancer (nonsquamous non-small cell lung cancer) that has worsened after immunotherapy. Researchers want to see if this new combination helps patients live longer without their cancer growing.